Varvara Solodovnikova
Biographic Data
| ID | 7866556 |
|---|---|
| NAME | Varvara Solodovnikova |
| GIVEN NAMES | Varvara |
| FAMILY NAME | Solodovnikova |
| SIGNATURE | SOLODOVNIKOVA V |
| AFFILIATIONS | Republican Scientific and Practical Centre of Pulmonology and Tuberculosis |
| ORCID | 0000-0003-1655-4000 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Prevalence, treatment, and outcomes of hepatitis C in an MDR/RR-TB trial cohort
Tuberculosis (TB) and chronic hepatitis C virus infection (HCV) remain significant global health challenges, especially in low- and middle-income countries. In Eastern Europe, a considerable percentage of multi-drug resistant (MDR) and rifampicin resistant (RR) TB populations show high HCV prevalence. Current WHO guidelines do not routinely advise HCV testing during MDR-TB treatment, despite HCV being a risk factor for drug-induced liver complica…
Tuberculosis Co-Infection Is Common in Patients Requiring Hospitalization for Covid-19 in Belarus
A significant drop in tuberculosis (TB) case-finding has been widely reported during the period of the COVID-19 pandemic. To address a decrease in TB notification, Belarus introduced laboratory TB testing in patients with the laboratory-confirmed coronavirus disease 2019 (COVID-19). We conducted a secondary analysis of health records among 844 patients with laboratory-confirmed COVID-19 diagnosis who were admitted to repurposed departments at TB …
No prominent works on this page.
Tuberculosis Co-Infection Is Common in Patients Requiring Hospitalization for Covid-19 in Belarus
A significant drop in tuberculosis (TB) case-finding has been widely reported during the period of the COVID-19 pandemic. To address a decrease in TB notification, Belarus introduced laboratory TB testing in patients with the laboratory-confirmed coronavirus disease 2019 (COVID-19). We conducted a secondary analysis of health records among 844 patients with laboratory-confirmed COVID-19 diagnosis who were admitted to repurposed departments at TB …
Prevalence, treatment, and outcomes of hepatitis C in an MDR/RR-TB trial cohort
Tuberculosis (TB) and chronic hepatitis C virus infection (HCV) remain significant global health challenges, especially in low- and middle-income countries. In Eastern Europe, a considerable percentage of multi-drug resistant (MDR) and rifampicin resistant (RR) TB populations show high HCV prevalence. Current WHO guidelines do not routinely advise HCV testing during MDR-TB treatment, despite HCV being a risk factor for drug-induced liver complica…
Internal Medicine (2 works) · Medicine (2 works) · Pathology (2 works) · Rifampicin (2 works) · Tuberculosis (2 works) · Tuberculosis Research and Epidemiology (2 works) · Adverse effect (1 work) · Cohort (1 work) · Cohort study (1 work) · Contact tracing (1 work)